Loading...
XSTO
BIOEX
, Last price  
SEK
Name

Bioextrax AB publ

Chart & performance

D1W1MN
XSTO:BIOEX chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
24.41%
Rev. 5Y
103.34%
Div Yld LY
—
Div Yld TTM
—
Revenues
757k
+46.99%
0021,776275,760395,0002,056,000515,000757,000
Net income
-18m
L+2.12%
-887,128-1,988,953-5,571,640-10,531,789-18,667,000-21,507,000-17,338,000-17,705,000
CFO
-26m
L+38.70%
520,506-3,170,444-4,173,153-8,476,713-17,604,000-23,310,000-18,778,000-26,046,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Bioextrax AB (publ) focuses on developing and commercializing a groundbreaking, biology-driven extraction system. This advanced technology facilitates the recovery of a variety of valuable materials from bacterial origins, such as bioplastic granules (PHA), organic hydrolyzed proteins, keratin fibers, different bio-oils, protein-rich co-products, and amino acids. The firm was founded in 2014 and conducts its operations from Lund, Sweden.
URL
https://bioextrax.com/
IPO date
Apr 28, 2020
Employees
Domiciled in
SE
Incorporated in
SE
Headquarters & legal address
Skiffervägen 76
Lund, M 224 78
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT